Nls Pharmaceutics Ltd (NLSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NLSP | PMCB | INDP | ||
| Company | Nls Pharmaceutics Ltd | Pharmacyte Biotech Inc | Indaptus Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.30 | 1.7200 | 1.0500 | ||
| High | 3.51 | 1.8100 | 1.0600 | ||
| Low | 3.19 | 1.6700 | 1.0200 | ||
| Last | 3.37 | 1.7500 | 1.0450 | ||
| Change | +0.08 | +0.0300 | -0.0150 | ||
| % Change | +2.28% | +1.74% | -1.42% | ||
| Volume | 33,400 | 7,500 | 9,000 | ||
| 20-Day Average Volume | 626,675 | 56,005 | 44,200 | ||
| Previous Close | 3.29 | 1.7200 | 1.0600 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.75 | 1.7830 | 1.1785 | ||
| 20-Day Raw Stochastic | 20.98% | 22.02% | 4.81% | ||
| 20-Day Relative Strength | 37.98% | 49.01% | 40.87% | ||
| Weighted Alpha | -85.13 | -27.48 | -59.41 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.75% since 11/14/24 | +1.85% since 11/14/24 | -7.11% since 11/14/24 | ||
| Low | 3.00 on 11/15/24 | 1.5600 on 11/15/24 | 1.0200 on 11/21/24 | ||
| High | 3.55 on 11/20/24 | 1.9249 on 11/19/24 | 1.2000 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | -29.31% since 10/21/24 | -2.78% since 10/21/24 | -28.91% since 10/21/24 | ||
| Low | 3.00 on 11/15/24 | 1.5600 on 11/15/24 | 1.0200 on 11/21/24 | ||
| High | 5.18 on 10/22/24 | 2.4229 on 10/30/24 | 2.0800 on 10/22/24 | ||
| 3-Month | |||||
| %Chg | -54.38% since 08/21/24 | -4.37% since 08/21/24 | -34.28% since 08/21/24 | ||
| Low | 3.00 on 11/15/24 | 1.3900 on 08/27/24 | 1.0200 on 11/21/24 | ||
| High | 7.40 on 08/22/24 | 2.4229 on 10/30/24 | 2.0800 on 10/22/24 | ||
| 6-Month | |||||
| %Chg | -45.02% since 05/21/24 | -16.27% since 05/21/24 | -55.53% since 05/21/24 | ||
| Low | 3.00 on 11/15/24 | 1.3900 on 08/27/24 | 1.0200 on 11/21/24 | ||
| High | 18.39 on 06/18/24 | 2.4229 on 10/30/24 | 3.1000 on 05/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,552 | 13,208 | 10,809 | ||
| Shares Outstanding, K | 3,815 | 7,679 | 10,197 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -12,170,000 | 330,000 | -15,420,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | 23,420,000 | -3,070,000 | ||
| 60-Month Beta | -0.51 | -0.20 | 1.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.14 on 09/16/24 | -0.32 on 11/12/24 | ||
| Latest Earnings Date | 08/21/24 | 12/20/24 | 11/18/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||